Analysts think VIR stock price could increase by 270%
Aug 12, 2025, 11:26 AM
20.00%
What does VIR do
Vir Biotechnology is a San Francisco-based clinical-stage immunology company focusing on treatments for infectious diseases, with a pipeline targeting HDV, HBV, HIV, and other viruses. The company went public on October 11, 2019, and employs 587 full-time staff.
9 analysts think VIR stock price will increase by 269.82%. The current median analyst target is $15.81 compared to a current stock price of $4.28. The lowest analysts target is $12.12 and the highest analyst target is $32.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.